pharmaceutical update or about therapeutics, but were ......pharmaceutical update or everything you...
TRANSCRIPT
PHARMACEUTICAL UPDATE or
Everything You Wanted to Know
About Therapeutics, But Were Afraid
to Ask-PART I
Bruce E. Onofrey, R.Ph., O.D. FAAO
Professor, U. Houston
University Eye Institute
TODAYS MENU
• CHOOSING A BETTER ANESTHETIC
• DEALING WITH DEFECTS (EPITH)
• DRY EYE-ALL THE ANGLES
• BLEPHARITIS-MYTHS VS TRUTHS
• VIRAL EYE DISEASE-A CURE(s)
Ester is NOT your Jewish aunt-
It’s a new approach to disease
management
• It’s about time we had a
better anesthetic than
proparacaine
Proparacaine-A good anesthetic for
the central cornea, but not much else.
Problems:Efficacy
No limbal or
conjunctival
coverage
Allergy
Name the best AMIDE anesthetic for
LASIK, topical cataract surgery and
lacrimal procedures.
• 1. Proparacaine
• 2. Tetracaine
• 3. Lidocaine
• 4. Cocaine
• 5. Benoxinate
• THINK AMIDES, NOT ESTERS
YOU DON’T NEED A NEEDLE
TO USE LIDOCAINE IN THE
EYE
Topical Lidocaine is a BETTER
anesthetic
• BENEFITS:
• NO CROSS SENSITIVITY
• EFFICACY ON VASCULAR
TISSUE
• NO LOCAL METABOLISM
• LONGER LASTING
Available dosage forms
• 50cc bottle 4%-can be
autoclaved
• 3.5% ophthalmic gel
• No preservatives
Want less bleeding and longer
action-THINK SYNERGISM
1 (+) 1 = 3
Epithelial defects-no problemo
• Better
patching
• Bandage lenses
• Corneal
micropuncture
• Doxycycline??
• Steroids??
• Vitamin C
Clinical Pearl#2: Don’t try to
Patch Without It@@@@@
• Proper technique requires
that the patient NOT be
wrapped like a mummy
with tape.
• Do not attach tape to
nose, ears or glasses
• One touch technique
• Requires adhesive-
Tincture of benzoin cmpd.
The Magic Skin Glue
Use the right tape
Corneal Erosion
MANAGEMENT 2.0
FIRST: HEAL IT
Bandage CL
8.4 BC
Prokera • Amniotic membrane on a
scaffold ring
• Functions as a bandage lens
• Healing properties?
• COST = $900
• REIMBUSEMENT = $1,400
SECOND: KEEP IT HEALED
• PEARL: Think Doxycycline (50mg BID)
• Watch out for smokers-Vitamin C (1-
2gm/D
• SALT OINT, NOT SOLUTION
THIRD: If it don’t heal-POKE
IT WITH A SHARP STICK
PAIN MGT OPTIONS:
Oxycodone, The “BIG GUN”• With ASA = Percodan
• With APAP = Percocett
• Schedule II drug = High
abuse
• Vicodin now schedule ll
• Tramadol (Ultram)
• 50mg, up to 400mg
max/D
• Usual 1-2 tabs QID PO
That all fine and good butttt:
• My Patients a drug abuser
• My Patient’s allergic to opiates
• I CAN’T prescribe Narcotic agents
• I don’t want to prescribe narcotic agents
• My patient doesn’t want to use dope
• @@@@@@@@
+
Know your “ABC’s” of OSD
• A = ALLERGY
• B = BLEPHARITIS
• C = KERATO- CONJUNCTIVITIS SICCA
Management of Dry Eye
• How do YOU spell D-R-Y E-Y-E
• Ocular surface disease is a serious
business
• Chronic condition
• Multiple dry eye factors
• Mild to severe presentations
Key(s) to managing dry eye?
• 1. ASK and QUANTIFY (SX’s)
• DO YOU HAVE DRY EYE?
• HOW BAD IS IT?
OCULAR SURFACE DISEASE INDEX (OSDI)
3 question sets
First set: Symptoms
Second set: Function
Third set: Environment
Scaled from (0) to (4)
Allows us to quantify and objectify subjective
data
OCULAR SURFACE DISEASE INDEX (OSDI)Please Answer The Following Questions by Checking The Box That Best Represents Your Answer
All of the time
(4)Most of the
time (3)Half of the
time (2)Some of
the time (1)None of the time
(0)
1 Eyes that are sensitive to light?
2 Eyes that feel gritty?
3 Painful or sore eyes?
4 Blurred vision?
5 Poor vision?
Have problems with your eyes limited you in performing any of the following during the last week:
All of the
time
Most of the
time
Half of the
time
Some of the
time
None of the
time
N/A
6 Reading?
7 Driving at night?
8 Working with a computer or bank
machine (ATM)?
9 Watching TV?
Have your eyes felt uncomfortable in any of the following situations during the last week:
All of the
time
Most of the
time
Half of the
time
Some of the
time
None of the
time
N/A
10 Windy conditions?
11 Placed or areas with low humidity
(very dry)?
12 Areas that are air conditioned?
Have you experienced any of the following during the last week:
SX
Activities
Environment
OSDI Severity Grading
Miller, K.L., Mink, D.R., Mathias, S.D, & Walt, J.G. (2006). Estimating the minimal clinical important difference of the Ocular Surface Disease
Index®: Preliminary findings [Abstract]. Abstract obtained from www.isoqol.org/2006AbstractsBook.pdf.
Severe
Total OSDI Score=
(Sum of Score for All Questions Answered) X (25)
(Total # of Questions Answered)
Mild ModerateNormal Severe
0 10 20 30 40 50 60 70 80 90 100
Score
0-12 23-3213-220 33-100
Key(s) to managing dry eye?
• 2. FIND THE CAUSE:
• DRY EYE IS A COMPLEX DISEASE!
Aging
Dry Environment
Hormonal Changes
Contact Lens
Blepharitis
LASIK
Auto-immune
Disease
Anti-histamine use
Alcohol Use
Pollution
Computer
Use
Anti-depressants
Dry Eye CascadeABNORMAL TEAR FILM CAUSES
& CONTRIBUTORS
OBSERVABLE
PATHOPHYSIOLOGIES
Drugs and Dry Eye
-A natural progression of disease-
ACCUTANE USE = DRY
EYE@@@@
Hold off on the CL’s:
TX as OSD patient
Aging
Dry Environment
Hormonal Changes
Contact Lens
Blepharitis
LASIK
Auto-immune Disease
Anti-histamine use
Alcohol Use
Pollution
Computer
Use
Anti-depressants
Quaternary
Ammoniums
(i.e. BAK)
Dry Eye CascadeABNORMAL TEAR FILM CAUSES
& CONTRIBUTORS
OBSERVABLE
PATHOPHYSIOLOGIES
BAK
Key(s) to managing dry eye?
• 2. OBJECTIVELY STAGE THE
DISEASE (SIGNS)
Key(s) to managing dry eye?
• 3. SELECT THE PROPER TX
• ACUTE VS CHRONIC
• APPROPRIATE FOR TYPE
• STEP THERAPY
Step therapy of dry eye
• DROPS CANNOT HEAL A SICK CORNEA
• PUT AWAY THE FORCEPS
MRS JOHNSON, THIS WON’T
HURT A BIT!!
The Sjogrens patient
• Starts with a bad cornea and serious
aqueous deficiency
• Acute and chronic disease
• TX?
DRY EYE: THE NEW WAY
• Mucomimetic drop/bandage
CL?
• OMEGA 3 : DHA / EPA
• Anti-inflammatory: Steroid
induction/Cyclosporin
A/Xibrom?
• Punctal occlusion
• Evoxac (Sjogrens)
Restasis VS Steroids for OSD
“Doctor Onofrey, You changed
my life”
Oral meds for dry eye?
Evoxac: New and improved
pilocarpine@@@@
• Parasympathomimetic@@@@@
• Better tolerated
• 30mg TID
• No titration necessary-maybe
• NEVER in asthmatics
Scoper H. Simplex in K.sicca
Patient study
KWESTION?
DOES PUNCTAL
OCCLUSION OR
CYCLOSPORIN
PREVENT
RECURRENT
DISCIFORM
HERPES?
Results• Non-treated group: 6-7 months of disease/yr
• TX with EITHER thermal cautery or topical
cyclosporin: 1.1 months/yr of active disease
• TX with both: 0.8 months/yr
• Learning point:
• OSD patients with H. simplex require
aggressive management
• Topical cyclosporin A is safe and effective in
H. simplex patients
THE DRY AND THE
HIGH
Evidence-based Management Strategies for
Glaucoma Patients with Ocular Surface
Disease (OSD)
Prostaglandins
Compliance sucks
This brings us to Rule #1
• Glaucoma docs do not talk to ocular surface disease docs
• They mix like oil and water
• They have their own meetings
• Their own separate Societies
• Secret handshakes
• Glaucoma guys drink wine and martinis
• OSD guys drink scotch (Think Art Epstein) and beer
Ocular Surface Disease Prevalence Study (Fechner)
Purpose: To Determine The Prevalence of OSD Symptoms in Glaucoma Patients
Methods:
– 10 Sites
– 630 Glaucoma Patients:
• > 18 Years of Age
• Primary Open-Angle, Exfoliation, or Pigment Dispersion Glaucoma, or Ocular Hypertension in Both Eyes
• Treated With a Topical IOP-Lowering Medication
– Patients Completed an OSDI Survey While in The Office
Fechtner, R, Budenz, D, Godfrey D. Prevalence of ocular surface disease symptoms in glaucoma patients on IOP-lowering
medications. Poster presented at: annual meeting of the American Glaucoma Society ; March 8, 2008; Washington DC.
OSD Prevalence Study: Results
Ranking Normal Mild Moderate Severe
Patients 325 134 84 87
Percentage 51.6% 21.3% 13.3% 13.8%
48.4%
Fechtner, R, Budenz, D, Godfrey D. Prevalence of ocular surface disease symptoms in glaucoma patients on IOP-lowering
medications. Poster presented at: annual meeting of the American Glaucoma Society ; March 8, 2008; Washington DC.
OSDI Scores in Glaucoma Patients
CL patient with GLC
Wears daily disp. SCL’s: “I Never
had problems till I started GLC
TX” (with you)
- 8.00 myope
“I WOULD RATHER GO BLIND
THAN WEAR GLASSES” Cornea
too thin for lasik – Management??
COMPLIANCE?
CAN THEY COME IN THE
SAME PACKAGE?• GLAUCOMA
• OCULAR SURFACE DISEASE
Initial presentation
• 62 Y/O F with POAG
• (+) FM HX POAG (M & F)
• Pre Tx IOP’s 28/25 (ADJUSTED)
Pachymetry: 530/533
TBUT: 2-3 seconds, with scattered
SPK
SX: FB sensation with burning in PM
A TX SUCCESS?
Mrs Johnson, Your GLC drops
are working great
• Prostaglandin drops HS OU started:
• 1 month recheck adjusted IOP’s: 18/17 @
10AM (ADJ)
• BUTTTTTTTTTT:
“Dr. My eyes feel like they are
on fire!!”
THE HARD TRUTH• PRE-TREATMENT GLC PATIENTS
WITH OSD ALWAYS GET WORSE
WITH CHRONIC USE OF MOST GLC
MEDS
• TX OSD FIRST, THEN START GLC
TX
• MONITOR BOTH CONDITIONS
BAK = BUY ANOTHER KIND
New Options for your
OSD/GLC patients #1
Blepharitis: Know your
anterior from your posterior
LID DISEASE-THEOLD
MYTH’s
• Blepharitis is curable
• Staph exotoxins produce the
inflammation
• Ointments are the best TX
• SCRUB your troubles away
• Patient’s love complex expensive
treatments
• All tetracyclines are the same
• There is no substitute for tetracycline
What Causes Chronic Staph
Lid Inflammation?
Exotoxins Right??!!
Staph epidemidis DOES NOT
produce exotoxins, but it does
produce a complex organic
molecule:
OH-POO=POO
LIPIDS (+) LIPASE = FATTY ACIDS
(STAPH POO)
Step Therapy of Blepharitis
RESULTS: Doxycycline significantly decreased IL-1beta
bioactivity in the supernatants from LPS-treated corneal
epithelial cultures. These effects were comparable to those
induced by the corticosteroid, @@@@
CONCLUSIONS: Doxycycline can suppress the
steady state amounts of mRNA and protein of IL-beta
and decrease the bioactivity of this major
inflammatory cytokine. These data may partially
explain the clinically observed anti-inflammatory
properties of doxycycline. The observation that
doxycycline was equally potent as a corticosteroid,
combined with the relative absence of adverse effects,
makes it a potent drug for a wide spectrum of ocular
surface inflammatory diseases.
RESULTS: Doxycycline significantly decreased IL-1beta
bioactivity in the supernatants from LPS-treated corneal
epithelial cultures. These effects were comparable to those
induced by the corticosteroid,
CONCLUSIONS: Doxycycline can suppress the steady
state amounts of mRNA and protein of IL-beta and
decrease the bioactivity of this major inflammatory
cytokine. These data may partially explain the clinically
observed anti-inflammatory properties of doxycycline.
The observation that doxycycline was
equally potent as a corticosteroid,
combined with the relative absence of
adverse effects, makes it a potent drug for
a wide spectrum of ocular surface
inflammatory diseases.
Posterior blepharitis: Azithromycin vs
Doxycycline
• Dose:
• Doxycycline 100mg BID X 1 month
• Azithromycin 500mg/D X 3 DMeasure Type Primary
Measure Title Change of Blepharitis Symptoms Score
Measure Description Five main ocular symptoms of posterior blepharitis
(itching, foreign body sensation, dryness, burning, and lid
swelling) will be asked of each patient and graded at
baseline, and days 7, 31, 37 and 61 after treatment. For
each item there was a question with scale from zero to
three (zero for no symptom three for maximum symptom).
Therefore, maximum score for symptoms was 15 (worse
outcome) and minimum score for symptoms was zero
(better outcome). Finally, we reported a change in total
score calculated as the latest time point (61 days) minus
the earliest time point.
Time FrameChange from the baseline until 61 days after
treatment
DON’T TX KIDS LIKE
LITTLE ADULTS: Pediatric
conjunctivitis plays by different
rulesDon’t treat pediatric conjunctivitis without
first:
• Check history
• Check ears
• Check throat
• Check temperature
• Orals for conjunctivitis??
Hemophilus TX Options
• Amoxicillin
• 25-45mg/kg if
less than 40kg
• Macrolide
• Cephalosporin
“But Doctor, I’m Allergic to
Penicillin”
Bacterial Corneal Ulcers
What is the Standard of Care?
OPTIONS
• Fluoroquinolones
• Fortified agents
Ophthalmic Antibiotics:
Fluoroquinolones• The first safe broad-spectrum ophthalmic
agents
• Revolutionized treatment of severe corneal
infections
• Very low sensitization rate
• Excellent safety profile
• Comfortable
• No reports of systemic effects
What percentage of all bacterial corneal
ulcers in a major study were successfully
treated with ciprofloxacin mono therapy?
• 1. 55%
• 2. 82%
• 3. 96%
• 4. 98%
• 5. 100%
What percentage of all bacterial corneal
ulcers in a major study were successfully
treated with ciprofloxacin mono therapy?
• 1. 55%
• 2. 82%@@@@
• 3. 96%
• 4. 98%
• 5. 100%
The greatest resistance to the drug is
in which type of bacteria?
• 1. Gram positive
• 2. Gram negative
The greatest resistance to the drug is
in which type of bacteria?
• 1. Gram positive@@@@
• 2. Gram negative
Sensitivity Profiles for Gram Positive Isolates
2001 (N=248) (Alvarez data, Bascom-Palmer)
67
66
64
90
32
67
100
88
0 20 40 60 80 100 120
penicillin
cefazolin
vancomycin
gentamicin
levofloxacin
ciprofloxacin
ofloxacin
trimethoprim
% sensitive
Reduced fluoroquinolone GR + activity
RESISTANT BACTERIA
• Methicillin resistant Staphylococcus aureus
• Enterococcus Fecalis (group DStreptococcus)
• Strep pneumoniae
• Haemophilus influenzae
• Aminoglycoside resistant Pseudomonas aeruginosa
• Beta lactamase producing Neisseria
• Atypical Mycobacteria
Laboratory Culture Report• Patient: Kerry Titus Age: 27
• Date: April 1, 2001 Source: Right cornea
• Time: 14:32 Physician: S. Kubrick
• Organism isolated: Staphylococcus aureus, coagulase-positive, methicillin-resistant
Drug Sensitivity Profile MIC
Interpretation
Cefazolin 8 Resistant
Oxacillin (methicillin) 30 Resistant
Amoxicillin/clavulanate potassium 6
Resistant
Ampicillin (injectable) 52 Resistant
Ciprofloxacin 8 Resistant
Vancomycin 1 Sensitive
Potency of Fluoroquinolones: MICs of 18
Fluoroquinolone-Resistant
Endophthalmitis Isolates*
Mather R, et al. Am J Ophthalmol. 2002;133:463-466.
0
10
20
30
40
50
60
70
Cip Ofx Lev Gat Mox
Me
dia
n M
IC
(µg
/mL
)
Coag-neg
Staphylococcus
S aureus
Current Standard of Care
75
Current Standard of Care?
76
Fourth-Generation Fluoroquinolone
Chemical Structures
HN
OCH3
F
N
O
COOH
N
H
H
MoxifloxacinGatifloxacin
HNOCH3
F
N
O
COOH
NH3C
•1.5 H2O
The Latest
Besivance: NEW Molecule
Moxeza: Longer duration
Zymaxid: Higher concentration
Moxeza/Zymaxid
• Just released-no change in active
ingredient
• Zymaxid: Increased concentration
• Moxeza: Gel vehicle: BID for
conjunctivitis only (CHROME!)
NEW: The worlds FIRST
Chloro-fluoroquinolone!!!
• WHAT THE HECK IS THAT?
• BESIFLOXACIN (BESIVANCE)
Refractive Surgery and Bacterial
Keratitis
• Cornea is already
compromised
• Infection is under flap
• Stroma is greatly thinned
• Must be aggressive
• Vancomycin (+)
amikacin/fluoroquinolone
SO MANY RED EYESCRITICAL SKILL #1
THE DX
In adults-Viral
conjunctivitis is the #1
Cause of
Acute INFECTIOUS
Conjunctivitis@@@@
Viral Pathogens
• Adenoviral
• Herpes simplex
• Herpes zoster
THE TESTSOLD AND NEW
• Cool compresses and ASA
• Lubrication
• Decongestants
• Steroids (infiltrates, membranes,
inflammation)@@@@
• Membrane removal
• Antibiotics??
• NOOOOOOOO!!!!!
• A CURE?
TREATMENT OF BOTH
SYMPTOMS AND PREVENTION
OF INFLAMMATORY DAMAGE
CHILL OUTTHE PEOPLES
CHOICE
Is there a Cure for the
Common Cold of the
eye?• Spit and swish: Povidone 5%
ophthalmic solution
• Don’t spare the steroids
Is there a Cure for the
Common Cold of the eye?
NOT QUITE
• Spit and swish: Povidone 5%
ophthalmic solution
• Don’t spare the steroids
THE CURE?
Decrease infection from 18 to 7 days
Fewer complications
Tabbara K, Jarade E. Ganciclovir effects in adenoviral
keratoconjunctivitis. Invest Ophthalmol Vis Sci.
Currently in Animal Testing
• FORESIGHT PHARMACEUTICALS
Topical FST100 Dexamethasone 0.1%
Containing Povidone-Iodine 0.4% Reduced the
Clinical Signs and Infectious Viral Titers in a
Rabbit Model of Adenoviral Conjunctivitis
Herpes Simplex• Primary disease
• Recurrent disease
Conjunctivitis
Keratitis
• Stromal disease
• Kerato-uveitis
GONE
Antiviral Agents
• IDU
• Vidarabine
• Trifluridine
• Ganciclovir
• Acyclovir
• Famcyclovir
• Valcyclovir
The NEW Way to TX H.
Simplex
THE OLD:Trifluorothymidine
THE NEW: Ganciclovir
• Was drug of choice for topical
management of Herpes
• simplex ocular disease.
• Rapid absorption
• Toxicity occurs when
• used over 21 days
• Dosage-5-8X daily
• Viroptic 1%-7.5cc-Burroughs
Epithelial herpes is associated
with the (2) BIG “I”’s
• Inflammation and Infection
X
DO YOU WANT STEROIDS
WITH THAT?
IOP = 62/ (+) 3 C AND F
The drugsssssss
+ +
+
Stromal H. simplex-
A whole new ball game
• Mechanism is primarily
inflammation@@@@
• Stromal infiltrates are the
critical sign
• Balanced use of topical
steroid (FML) with anti-viral
cover@@@@
• Consider oral acyclovir at
this point in time
Tapering 1.0
Herpes simplex disciform
disease
Herpes Zoster• Commonly called
“shingles”
• Lesions “HONOR” the
mid-line
• Reoccurrence triggered by
decreased immunity-
MUST consider cause of
reoccurrence
Who gets Post-herpetic
Neuralgia@@@@
• Immunocompromised folk
• The elderly
• Best treatment is prophylactic TX
Manage Potential Post-herpetic
Neuralgia@@@@
• Oral acyclovir 800mg 5X daily
• Valacyclovir 1000mg TID
• Famcyclovir 500mg TID
• Low dose tricyclic antidepressant-
amitryptyline 25mg/day
• Neurontin
Chronic neural pain-A
different kind of animal
Neurontin: The New “Big Dog”
for chronic pain
• Huge dosage range: 100-5000mg/d
• Must start slow
• Must give enough
Narcotics and Zoster pain
• OK for short term ACUTE H. zoster
• Not best for late phase post-zoster
trigeminal neualgia
• Vicodin = Tylenol + hydrocodone works
well@@@@@
• Many side-effects = constipation,
drowsiness and nausea@@@@
DO YOU WANT STEROIDS
WITH THAT?
THE REST OF THE STORY
A REAL “DIZ-OSTER
Pavan-Langston et al performed polymerase chain
reaction studies on patient’s excised corneal tissue
and the response of patients to antiviral therapy.
They concluded that recurrent viral infection by
VZV may play a role in this late manifestation of the
disease, associated with MPK; thus, specific
antiviral therapy may be warranted in the treatment
of MPK. Specific antiviral therapy was not
consistently successful in all cases, but topical
trifluridine, vidarabine, and oral acyclovir were
individually used successfully in different cases.22
The use of newer topical and oral antivirals may
improve the general success rate of treatment.
The drugsssssss
+
+ +
HOW DO YOU TAPER YOUR ‘ROIDS?
Version 2.0
HOW ABOUT 1-2-3
1 2 3